Pasithea Therapeutics (KTTA) Debt to Equity (2022 - 2023)
Pasithea Therapeutics (KTTA) has disclosed Debt to Equity for 2 consecutive years, with $0.0 as the latest value for Q2 2023.
- Quarterly Debt to Equity changed N/A to $0.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $0.0 through Jun 2023, changed N/A year-over-year, with the annual reading at $0.0 for FY2022, N/A changed from the prior year.
- Debt to Equity hit $0.0 in Q2 2023 for Pasithea Therapeutics, down from $0.0 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.0 in Q1 2023 to a low of $0.0 in Q2 2023.